Characterization and chondrogenic differentiation of menstrual blood-derived stem cells on a nanofibrous scaffold

International Journal of Artificial Organs

Volumn 35, Issue 1, 2012, Pages 55-66

  Kazemnejad, Somaieh ^a,b   Akhondi, Mohammad Mehdi ^a   Soleimani, Masoud ^c   Zarnani, Amir Hassan ^a,d   Khanmohammadi, Manijeh ^a   Darzi, Saeedeh ^d   Alimoghadam, Kamran ^e  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chondrogenic differentiation; Menstrual blood derived stem cells; Nanofiber; Scaffold

Indexed keywords

BLOOD; BONE; CARTILAGE; CELL CULTURE; CELL ENGINEERING; CELL PROLIFERATION; ENZYME ACTIVITY; MONOCLONAL ANTIBODIES; NANOFIBERS; POLYCAPROLACTONE; SCAFFOLDS (BIOLOGY); SCANNING ELECTRON MICROSCOPY;

BONE MARROW; CELL-BE; CELL/B.E; CELL/BE; CHONDROGENIC DIFFERENTIATION; MARROW-DERIVED STEM CELLS; MENSTRUAL BLOOD-DERIVED STEM CELL; NANOFIBROUS SCAFFOLDS; STEM-CELL; TISSUES ENGINEERINGS;

STEM CELLS;

ALCIAN BLUE; COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN; MOLECULAR SCAFFOLD; MONOCLONAL ANTIBODY; OCTAMER TRANSCRIPTION FACTOR 4; POLYCAPROLACTONE; BIOLOGICAL MARKER; NANOFIBER; POLYESTER; PROTEOGLYCAN; TISSUE SCAFFOLD;

ADULT; ARTICLE; CARTILAGE CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; CULTURE MEDIUM; DENSITY GRADIENT CENTRIFUGATION; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOREACTIVITY; MENSTRUAL BLOOD DERIVED STEM CELL; MENSTRUATION; MESENCHYMAL STEM CELL; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEOGLYCAN SYNTHESIS; SCANNING ELECTRON MICROSCOPE; STEM CELL; STEM CELL EXPANSION; TISSUE ENGINEERING; BLOOD; BONE MARROW CELL; CELL ADHESION; CELL CULTURE; CELL SEPARATION; CHEMISTRY; COMPARATIVE STUDY; CULTURE TECHNIQUE; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; NANOTECHNOLOGY; PHENOTYPE; PHYSIOLOGY; POROSITY; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TIME; ULTRASTRUCTURE;

BIOLOGICAL MARKERS; BONE MARROW CELLS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; COLLAGEN TYPE II; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; GLYCOSAMINOGLYCANS; HUMANS; IMMUNOPHENOTYPING; MENSTRUATION; MICROSCOPY, ELECTRON, SCANNING; NANOFIBERS; NANOTECHNOLOGY; PHENOTYPE; POLYESTERS; POROSITY; PROTEOGLYCANS; STEM CELLS; SURFACE PROPERTIES; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84862261872     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000019     Document Type: Article

References (41)

1. Kuo CK, Li WJ, Mauck RL, Tuan RS. Cartilage tissue engineering: its potential and uses. Curr Opin Rheumatol. 2006;18:64-73. Medline. doi:10.1097/01.bor.0000198005.88568.df
2. Henningson CT, Stanislaus MA, Gewirtz AM. Embryonic and adult stem cell therapy. J Allergy Clin Immunol. 2003;111(2 Suppl 2):745-753. doi:10.1067/mai.2003.133
3. Phinney DG. Isolation of mesenchymal stem cells from murine bone marrow by immunodepletion. Methods Mol Biol. 2008;449:171-186. Medline. doi:10.1007/978-1-60327-169-1_12
4. Lee MW, Jang IK, Yoo KH, Sung KW, Koo HH. Stem and progenitor cells in human umbilical cord blood. Int J Hematol. 2010;92(1):45-51. Medline. doi:10.1007/s12185-010-0619-4
5. Da Sacco S, Sedrakyan S, Boldrin F, et al. Human amni 2004.07.062 otic fluid as a potential new source of organ specific precursor cells for future regenerative Medicine applications. J Urol. 2010;183(3):1193-1200. Medline. doi:10.1016/j. juro.2009.11.006
6. Mizuno H. Adipose-derived stem and stromal cells for cellbased therapy: current status of preclinical studies and clinical trials. Curr Opin Mol Ther. 2010;12(4):442-449. Medline.
7. Ronzière MC, Perrier E, Mallein-Gerin F, Freyria AM. Chondrogenic potential of bone marrow- and adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng. 2010; 1; 20(3):145-58.
8. Kazemnejad S, Allameh A, Gharehbaghian A, Soleimani M, Amirizadeh N, Jazayeri M. Efficient replacing of fetal bovine serum with human platelet releasate during propagation and differentiation of human bone marrow derived mesenchymal stem cells to functional hepatocytes-like cells. Vox Sang. 2008;95(2):149-158. Medline. doi:10.1111/j.1423-0410.2008.01075.x
9. Schneider RK, Neuss S, Knüchel R, Perez-Bouza A. Mesenchymal stem cells for bone tissue engineering. Pathologe. 2010;31(Suppl 2):138-146. Medline. doi:10.1007/s00292-010-1329-7
10. Singla DK. Stem cells in the infarcted heart. J Cardiovasc Transl Res. 2010;3(1):73-78. Medline. doi:10.1007/s12265-009-9151-4
11. Patel AN, Park E, Kuzman M, Benetti F, Silva F, Allickson J. Multipotent Menstrual Blood Stromal Stem Cells: Isolation, Characterization, and Differentiation. Cell Transplant. 2008;17:303-311. Medline. doi:10.3727/096368908784153922
12. McLennan CE, Rydell AH. Extent of endometrial shedding during normal menstruation. Obstet Gynecol. 1965;26:605-621.
13. Musina RA, Belyavski AV, Tarusova OV, Solovyova EV, Sukhikh GT. Endometrial mesenchymal stem cells isolated from the menstrual blood. Bull Exp Biol Med. 2008;145(4):539-543. Medline. doi:10.1007/s10517-008-0136-0
14. Hida N, Nishiyama N, Shunichiro M, et al. Novel Cardiac Precursor-Like Cells from Human Menstrual Blood-Derived Mesenchymal Cells. Stem Cells. 2008;26:1695-1704. Medline. doi:10.1634/stemcells.2007-0826
15. Toyoda M, Cui Ch, Umezawa A. Myogenic transdifferentiation of menstrual blood-derived cells. Acta Myol. 2007;26(3):176-178.
16. Zhang MJ, Liu B, Xia W, Sun ZY, Lu KH. Could cells from menstrual blood be a new source for cell-based therapies? Med Hypotheses. 2009;72(3):252-254. Medline. doi:10.1016/j.mehy.2008.10.021
17. Kazemnejad S, Allameh A, Soleimani M, et al. Functional hepatocyte-like cells derived from human bone marrow mesenchymal stem cells on a novel 3-dimensional biocompatible nanofibrous scaffold. Int J Artif Organs. 2008;31(6):500-507.
18. Shabani I, Haddadi-Asl V, Seyedjafari E, Babaeijandaghi F, Soleimani M. Improved infiltration of stem cells on electrospun nanofibers. Biochem Biophys Res Commun. 2009; 382(1):129-133.
19. Li WJ, Danielson KG, Alexander PG, Tuan RS. Biological response of chondrocytes cultured in three-dimensional nanofibrous poly (ε-caprolactone) scaffolds. J Biomed Mater Res. 2003;67:1105-1114.
20. Li WJ, Tuli R, Okafor C, et al. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials. 2005;26:599-609. Medline. doi:10.1016/j.biomaterials.2004.03.005
21. Moutos FT, Guilak F. Functional properties of cell-seeded three-dimensionally woven poly(epsilon-caprolactone) scaffolds for cartilage tissue engineering. Tissue Eng Part A. 2010;16(4):1291-1301. Medline. doi:10.1089/ten.tea.2009.0480
22. Li WJ, Cooper JA, Mauck R, Tuan RS. Fabrication and characterization of six electrospun poly (α-hydroxy ester)-based fibrous scaffolds for tissue engineering applications. Acta Biomater. 2006;2(4):377-385. Medline. doi:10.1016/j.actbio.2006.02.005
23. Neves SC, Moreira Teixeira LS, Moroni L, et al. Chitosan/Poly(-caprolactone) blend scaffolds for cartilage repair. Biomaterials. 2011;32(4):1068-1079. Medline. doi:10.1016/j.biomaterials.2010.09.073
24. Zhong Z, Patel AN, Ichim TE, et al. Feasibility investigation of allogeneic endometrial regenerative cells. J Transl Med. 2009;7:15. Medline. doi:10.1186/1479-5876-7-15
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63. Medline.doi:10.1016/0022-1759(83)90303-4
26. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986;883(2):173-177.
27. Meng X, Ichim TE, Zhong J, et al. Endometrial regenerative cells: A novel stem cell population. J Transl Med. 2007;5:57. Medline. doi:10.1186/1479-5876-5-57
28. Vacanti JP, Langer R, Upton J, Marler JJ. Transplantation of cells in matrices for tissue regeneration. Adv Drug Deliv Rev. 1998;33(1-2):165-182. Medline. doi:10.1016/S0169-409X(98)00025-8
29. Smith LA, Ma PX. Nano-fibrous scaffolds for tissue engineering. Colloids Surf B Biointerfaces. 2004;39(3):125-131. Medline.
30. Yang J, Bei J, Wang S. Improving cell affinity of poly (D, L-Lactide) film modified by anhydrous ammonia plasma treatment. Polym Adv Technol. 2002(3-4);13: 220-226. doi:10.1002/pat.177
31. Ryu GH, Yang WS, Roh W, et al. Plasma surface modification of poly (D, L-lactic-co-glycolic acid) film for tissue engineering. Surf Coat Tech. 2005;193(1-3):60-64. doi:10.1016/j.surfcoat.2004.07.062
32. Duan Y, Wang Z, Yan W, Wang S, Zhang S, Jia J. Preparation of collagen coated electrospun nanofibers by remote plasma treatment and their biological properties. J Biomater Sci Polym Ed. 2007;18(9):1153-1164. doi:10.1163/156856207781554019
33. Grinnell F. Cellular adhesiveness and extracellular substrata. Int Rev Cytol. 1978;53:65-144. Medline. doi:10.1016/S0074-7696(08)62241-X
34. Pilgaard L, Lund P, Duroux M, et al. Effect of oxygen concentration, culture format and donor variability on in vitro chondrogenesis of human adipose tissue derived stem cells. Regen Med. 2009;4(4):539-548. Medline. doi:10.2217/rme.09.28
35. Janjanin S, Li WJ, Morgan MT, Shanti RM, Tuan RS. Mold-Shaped, Nanofiber Scaffold-Based Cartilage Engineering Using Human Mesenchymal Stem Cells and Bioreactor. J Surg Res. 2008;149(1):47-56. Medline. doi:10.1016/j.jss.2007.12.788
36. Ma Z, Gao C, Gong Y, Shen J. Cartilage tissue engineering PLLA scaffold with surface immobilized collagen and basic fibroblast growth factor. Biomaterials. 2005;26(11):1253-1259. Medline. doi:10.1016/j.biomaterials.2004.04.031
37. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 1998;238(1):265-272. Medline. doi:10.1006/excr.1997.3858
38. Sakimura K, Matsumoto T, Miyamoto C, Osaki M, Shindo H. Effects of insulin-like growth factor I on transforming growth factor beta1induced chondrogenesis of synovium-derived mesenchymal stem cells cultured in a polyglycolic acid scaffold. Cells Tissues Organs. 2006;183(2):55-61. Medline. doi:10.1159/000095509
39. Tew SR, Murdoch AD, Rauchenberg RP, Hardingham TE. Cellular methods in cartilage research: Primary human chondrocytes in culture and chondrogenesis in human bone marrow stem cells. Methods. 2008;45(1):2-9. Medline. doi:10.1016/j.ymeth.2008.01.006
40. Aigner T, Stove J. Collagens-major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv Drug Deliv Rev. 2003;55(12):1569-1593. Medline. doi:10.1016/j.addr.2003.08.009
41. Zheng L, Fan HS, Sun J, et al. Chondrogenic differentiation of mesenchymal stem cells induced by collagenbased hydrogel: An in vivo study. J Biomed Mater Res A. 2010;93(2):783-792.